Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - Myovant Sciences Ltd.myovantex311.htm
EX-32.1 - EXHIBIT 32.1 - Myovant Sciences Ltd.myovantex321.htm
EX-31.2 - EXHIBIT 31.2 - Myovant Sciences Ltd.myovantex312.htm
EX-23.1 - EXHIBIT 23.1 - Myovant Sciences Ltd.myovantex231.htm
EX-21.1 - EXHIBIT 21.1 - Myovant Sciences Ltd.myovantex211.htm
EX-10.26 - EXHIBIT 10.26 - Myovant Sciences Ltd.myovantex1026.htm
10-K - 10-K - Myovant Sciences Ltd.myovant10kmarch312018.htm


Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Myovant Sciences Ltd. (the “Company”) for the period ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Frank Karbe, Principal Financial Officer of the Company, hereby certifies, pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and 18 U.S.C. Section 1350, that to the best of his knowledge:
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 7, 2018
By:
/s/ Frank Karbe
 
 
Frank Karbe
 
 
Principal Financial Officer

This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.